WO2004065609A1 - アシルコエンザイムaを用いるアシル基転移酵素反応方法 - Google Patents
アシルコエンザイムaを用いるアシル基転移酵素反応方法 Download PDFInfo
- Publication number
- WO2004065609A1 WO2004065609A1 PCT/JP2004/000500 JP2004000500W WO2004065609A1 WO 2004065609 A1 WO2004065609 A1 WO 2004065609A1 JP 2004000500 W JP2004000500 W JP 2004000500W WO 2004065609 A1 WO2004065609 A1 WO 2004065609A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acyl
- reaction
- coa
- acyl group
- enzyme
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 113
- 238000006911 enzymatic reaction Methods 0.000 title claims abstract description 26
- 229940093530 coenzyme a Drugs 0.000 title claims abstract description 13
- 230000008569 process Effects 0.000 title claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 128
- 125000002252 acyl group Chemical group 0.000 claims abstract description 122
- -1 acyl thioester Chemical class 0.000 claims abstract description 50
- 150000001875 compounds Chemical class 0.000 claims abstract description 45
- 229920000642 polymer Polymers 0.000 claims abstract description 38
- 239000000126 substance Substances 0.000 claims abstract description 21
- 229920000728 polyester Polymers 0.000 claims abstract description 13
- 239000005516 coenzyme A Substances 0.000 claims abstract description 12
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 claims abstract description 10
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 claims abstract description 9
- 102000004190 Enzymes Human genes 0.000 claims description 86
- 108090000790 Enzymes Proteins 0.000 claims description 86
- 238000004519 manufacturing process Methods 0.000 claims description 46
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims description 44
- 150000007970 thio esters Chemical group 0.000 claims description 44
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims description 43
- 102000057234 Acyl transferases Human genes 0.000 claims description 32
- 108700016155 Acyl transferases Proteins 0.000 claims description 32
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 claims description 26
- 102000015785 Serine C-Palmitoyltransferase Human genes 0.000 claims description 16
- 108010024814 Serine C-palmitoyltransferase Proteins 0.000 claims description 16
- 150000003410 sphingosines Chemical class 0.000 claims description 16
- 108010010718 poly(3-hydroxyalkanoic acid) synthase Proteins 0.000 claims description 15
- 230000000379 polymerizing effect Effects 0.000 claims description 10
- 238000005820 transferase reaction Methods 0.000 claims description 9
- 229940106189 ceramide Drugs 0.000 claims description 6
- 230000001172 regenerating effect Effects 0.000 claims description 6
- 241000232299 Ralstonia Species 0.000 claims description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
- 150000002148 esters Chemical group 0.000 claims description 5
- PQDSZMWXZDOGQE-UHFFFAOYSA-N thiophen-2-yl 3-hydroxybutanoate Chemical group CC(O)CC(=O)OC1=CC=CS1 PQDSZMWXZDOGQE-UHFFFAOYSA-N 0.000 claims description 5
- KBUNOSOGGAARKZ-KRWDZBQOSA-N 3-dehydrosphinganine Chemical group CCCCCCCCCCCCCCCC(=O)[C@@H](N)CO KBUNOSOGGAARKZ-KRWDZBQOSA-N 0.000 claims description 4
- 241001528539 Cupriavidus necator Species 0.000 claims description 4
- 241000481518 Ralstonia eutropha H16 Species 0.000 claims description 4
- 150000001783 ceramides Chemical class 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000736131 Sphingomonas Species 0.000 claims description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 229920000739 poly(3-hydroxycarboxylic acid) polymer Polymers 0.000 claims description 3
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 1
- 102000002579 Sphingosine N-acyltransferase Human genes 0.000 claims 1
- 108020004714 Sphingosine N-acyltransferase Proteins 0.000 claims 1
- 102000004896 Sulfotransferases Human genes 0.000 claims 1
- 108090001033 Sulfotransferases Proteins 0.000 claims 1
- 150000003855 acyl compounds Chemical class 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 229930192474 thiophene Natural products 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 23
- 230000015572 biosynthetic process Effects 0.000 abstract description 14
- 238000009776 industrial production Methods 0.000 abstract description 9
- 239000000243 solution Substances 0.000 description 116
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- 238000006116 polymerization reaction Methods 0.000 description 41
- 239000000203 mixture Substances 0.000 description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 34
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 30
- 239000000047 product Substances 0.000 description 25
- 238000003756 stirring Methods 0.000 description 25
- 238000005481 NMR spectroscopy Methods 0.000 description 24
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 22
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000758 substrate Substances 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 244000005700 microbiome Species 0.000 description 16
- WHBMMWSBFZVSSR-GSVOUGTGSA-M (R)-3-hydroxybutyrate Chemical compound C[C@@H](O)CC([O-])=O WHBMMWSBFZVSSR-GSVOUGTGSA-M 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 238000010168 coupling process Methods 0.000 description 12
- 238000011069 regeneration method Methods 0.000 description 12
- 238000000338 in vitro Methods 0.000 description 11
- 229920002521 macromolecule Polymers 0.000 description 11
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 11
- 235000019341 magnesium sulphate Nutrition 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 11
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 239000003480 eluent Substances 0.000 description 10
- 229910000160 potassium phosphate Inorganic materials 0.000 description 10
- 235000011009 potassium phosphates Nutrition 0.000 description 10
- 230000008929 regeneration Effects 0.000 description 10
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 150000003408 sphingolipids Chemical class 0.000 description 9
- 238000006276 transfer reaction Methods 0.000 description 9
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 8
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 230000000813 microbial effect Effects 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 229960001153 serine Drugs 0.000 description 7
- 238000005924 transacylation reaction Methods 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 5
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- UDRCONFHWYGWFI-UHFFFAOYSA-N ethyl 3-oxopentanoate Chemical compound CCOC(=O)CC(=O)CC UDRCONFHWYGWFI-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000005809 transesterification reaction Methods 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 102000004357 Transferases Human genes 0.000 description 3
- 108090000992 Transferases Proteins 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229920002988 biodegradable polymer Polymers 0.000 description 3
- 239000004621 biodegradable polymer Substances 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000007805 chemical reaction reactant Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000012262 fermentative production Methods 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- ZNJHFNUEQDVFCJ-UHFFFAOYSA-M sodium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OCCN1CCN(CCS(O)(=O)=O)CC1 ZNJHFNUEQDVFCJ-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 108010049926 Acetate-CoA ligase Proteins 0.000 description 2
- 102100035709 Acetyl-coenzyme A synthetase, cytoplasmic Human genes 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 102100037458 Dephospho-CoA kinase Human genes 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 241000672609 Escherichia coli BL21 Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 208000037534 Progressive hemifacial atrophy Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 108010049285 dephospho-CoA kinase Proteins 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000002339 glycosphingolipids Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000012017 passive hemagglutination assay Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 239000012492 regenerant Substances 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- OTKJDMGTUTTYMP-ZWKOTPCHSA-N sphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ZWKOTPCHSA-N 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 150000003573 thiols Chemical group 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- REKYPYSUBKSCAT-SCSAIBSYSA-N (R)-3-hydroxypentanoic acid Chemical compound CC[C@@H](O)CC(O)=O REKYPYSUBKSCAT-SCSAIBSYSA-N 0.000 description 1
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 1
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical compound SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 description 1
- PWOBDMNCYMQTCE-UHFFFAOYSA-N 2-chlorobenzenethiol Chemical compound SC1=CC=CC=C1Cl PWOBDMNCYMQTCE-UHFFFAOYSA-N 0.000 description 1
- NRENOZNSHMLGOF-UHFFFAOYSA-N 2-sulfanyltriazole Chemical compound SN1N=CC=N1 NRENOZNSHMLGOF-UHFFFAOYSA-N 0.000 description 1
- 101710161460 3-oxoacyl-[acyl-carrier-protein] synthase Proteins 0.000 description 1
- OCVLSHAVSIYKLI-UHFFFAOYSA-N 3h-1,3-thiazole-2-thione Chemical compound SC1=NC=CS1 OCVLSHAVSIYKLI-UHFFFAOYSA-N 0.000 description 1
- 108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 description 1
- 102000005345 Acetyl-CoA C-acetyltransferase Human genes 0.000 description 1
- 102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 1
- 108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 1
- 108010032178 Amino-acid N-acetyltransferase Proteins 0.000 description 1
- 102000007610 Amino-acid N-acetyltransferase Human genes 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010066477 Carnitine O-acetyltransferase Proteins 0.000 description 1
- 102100036357 Carnitine O-acetyltransferase Human genes 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000190831 Chromatium Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000190986 Ectothiorhodospira Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 1
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 1
- 108700024327 Phosphate butyryltransferases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241001276012 Wickerhamomyces ciferrii Species 0.000 description 1
- LUCKFPBUROIZRT-BLPRJPCASA-N [Na].CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)n1cnc2c(N)ncnc12)[C@@H](O)C(=O)NCCC(=O)NCCS Chemical compound [Na].CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)n1cnc2c(N)ncnc12)[C@@H](O)C(=O)NCCC(=O)NCCS LUCKFPBUROIZRT-BLPRJPCASA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 108700014220 acyltransferase activity proteins Proteins 0.000 description 1
- MGSKVZWGBWPBTF-UHFFFAOYSA-N aebsf Chemical compound NCCC1=CC=C(S(F)(=O)=O)C=C1 MGSKVZWGBWPBTF-UHFFFAOYSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- YVHPHQBRUPLYOS-UHFFFAOYSA-N dichloromethane;methane Chemical compound C.ClCCl YVHPHQBRUPLYOS-UHFFFAOYSA-N 0.000 description 1
- OTKJDMGTUTTYMP-UHFFFAOYSA-N dihydrosphingosine Natural products CCCCCCCCCCCCCCCC(O)C(N)CO OTKJDMGTUTTYMP-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- OMSUIQOIVADKIM-UHFFFAOYSA-N ethyl 3-hydroxybutyrate Chemical compound CCOC(=O)CC(C)O OMSUIQOIVADKIM-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 238000013418 fluorescence derivatisation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- XIRNKXNNONJFQO-UHFFFAOYSA-N hexadecanoic acid ethyl ester Natural products CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- LTYOQGRJFJAKNA-VFLPNFFSSA-N malonyl-coa Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-VFLPNFFSSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- RZKVHIPRDKHSAJ-UHFFFAOYSA-N octyl hydrogen carbonate Chemical compound CCCCCCCCOC(O)=O RZKVHIPRDKHSAJ-UHFFFAOYSA-N 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- MNBKLUUYKPBKDU-BBECNAHFSA-N palmitoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MNBKLUUYKPBKDU-BBECNAHFSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 150000003881 polyketide derivatives Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000006829 sphingolipid biosynthesis Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000006491 synthase reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- PQDSZMWXZDOGQE-ZCFIWIBFSA-N thiophen-2-yl (3r)-3-hydroxybutanoate Chemical compound C[C@@H](O)CC(=O)OC1=CC=CS1 PQDSZMWXZDOGQE-ZCFIWIBFSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C12P7/625—Polyesters of hydroxy carboxylic acids
Definitions
- the present invention relates to a method for reacting an acyltransferase to various organic compounds by using acylcoenzyme A (hereinafter, coenzyme A may be referred to as CoA). More specifically, the present invention relates to a process for producing an acylated product using an acyltransferase, wherein the reaction is carried out continuously without adding an extremely expensive The present invention relates to a novel acyltransferase reaction method which enables the use of acyltransferases for industrial production of various compounds by dramatically improving the method.
- the present invention relates to a CoA enzymatic coupling method in which a chemical thioesterification reaction is used as an acyl CoA regeneration system.
- the present invention also relates to a method for producing an important physiologically active substance such as a sphingolipid using a CoA enzyme.
- the present invention relates to a method for producing a polymer compound by an enzyme reaction. More specifically, the thioester exchange reaction and the high-molecular-weight polymerizing enzyme reaction coexist to regenerate the acylcoenzyme (Acil CoA) in the reaction system, thereby synthesizing the polymer compound from the thioester power consistently.
- the present invention relates to a method for producing an efficient biodegradable polymer compound, particularly a polyester, which can be used. Background art
- CoA is a substance that functions as an acyl carrier / activator in all species.
- acetyl COA is a key substance in biological metabolism such as fatty acid and glucose that pass through the citrate cycle.
- o A derivatives also play an important role in cholesterol and fatty acid biosynthesis.
- CoA is an essential and indispensable substance as a capture factor (enzyme) for the enzyme-catalyzed reaction (CoA enzyme) involved in these metabolisms, and is represented by the following formula.
- ACY is an acyl group.
- CoA enzymes depending on the structure of the acyl group to be transferred and the substrate (compound into which the acyl group is introduced).
- substrate compound into which the acyl group is introduced.
- CoA enzymes for example, production of various antibiotics, drugs, various iridescent substances utilizing the polyketide synthesis pathway, amino acids, There are production examples of polyhydroxy acids and the like.
- acyl CoA is consumed in the reaction equimolar to the acyl acceptor. Therefore, it is necessary to produce the required acyl COA at low cost.
- in-vivo acyl CoA produced by fermentation is used, or acyl CoA produced separately from the production system.
- in vivo fermentatively produced in vivo COA the in vivo produced Only certain acyl COAs, such as chill COA and malonyl COA, are available.
- chill COA and malonyl COA the in vivo produced Only certain acyl COAs, such as chill COA and malonyl COA.
- the method using acyl CoA produced separately from the production system is a versatile and commonly used method, but the acyl CoA produced in this way is extremely expensive. Equimolar amounts are still required for use in the group transfer reaction.
- Examples of the method for producing acyl CoA include a chemical synthesis method using an acyl chloride, a chemical synthesis method using an acid anhydride, a chemical synthesis method using a mixed acid anhydride with octyl carbonate, and a chemical synthesis method using a thioester exchange.
- J. Am. Chem. Soc, 1953, 75, 2520, J. Biol. Chem., 1985, 260 , 13181 and many other chemical synthesis methods are commonly used.
- Sphingo lipids are lipids derived from sphingoid bases such as sphingosin and are present in the cell membranes of animals, plants and microorganisms. The exact function of human sphingolipids is not yet known, but these compounds are involved in nervous system electrical signaling and cell membrane stabilization. Glycosphingolipids have functions in the immune system, and in particular certain glycosphingolipids have been shown to function as receptors for bacterial toxins, and possibly also as bacteria and viruses.
- Ceramides are a specific group of sphingolipids that contain sphingosine, dihydrosphingosine or bithsphingosine as a base. Ceramide is a major lipid component of the stratum corneum, the upper layer of skin, and has an important barrier function. have. Topical topical applications containing sphingolipids such as ceramides are known to improve, for example, the barrier function and moisture retention properties of the skin (Curatolo, Pharm. Res., 4: 271-277). (1987); Kerscher et al., Eur. J. Dermatol "1: 39-43 (1991).
- Sphingoid bases themselves have been shown to mediate some physiological effects by inhibiting the activity of protein kinase C, a key enzyme in the signaling pathway.
- sphingoid bases are included in cosmetic compositions or dermatological compositions for their anti-inflammatory and antimicrobial activities.
- xenobiotic sphingolipid preparations for cosmetics are mainly extracted from animal sources, but are not only relatively expensive methods on an industrial scale, but also include those for e.g. spongiform encephalopathy (BSE).
- BSE spongiform encephalopathy
- Microorganisms such as the yeast Pichia ciferrii have been found to produce sphingolipids, sphingosine, phytosphingosine and / or their derivatives (Wickerham and Stodola, J. Bacteriol., 80: 484-491 ( 1960)). It provides a source of sphingolipids on its own, and a source of starting material to produce other commercially valuable compounds, and provides a viable substitute for the use of animal sources of these compounds. give.
- microbial production is difficult to improve productivity due to the toxicity of sphingoid bases to microbial cells (Pinto et al., J. Bacteriol., 174: 2565-2574 (1992); Bibel et al., J. Invest. Dermatol., 93: 269-273 (1992)), and it has been desired to provide a more efficient production method.
- PHA polyhydroxyalkanoate
- PHB polyhydroxybutylate
- PHV poly (3-hydroxypallate)
- PHB-co-PHV poly ( 3-Hydroxybutylate-co-3-Hydroxyvalerate
- JP-A-57-150393 US Pat. No. 4,393,167
- JP-A-59-220192 European Patent Publication No. 0114086
- JP-A-63-226291 Gazette '(European Patent Publication No. 0274151), JP-A-63-269989).
- the productivity is low due to accumulation of PHA in the microorganisms, and there are many problems such as high costs for crushing the microorganisms and extracting and refining the PHA.
- a method for producing PHA by fermentative production of microorganisms does not always produce a desired PHA due to a complicated metabolic pathway, and the variation of PHA is limited. Also, depending on the method of controlling fermentation production, it may become a copolymer instead of a desired homopolymer, and conversely, a copolymer. Even in one production, a homogeneous copolymer having a desired polymerization ratio cannot always be produced (FEMS Microbiol. Rev., 1992, 103, 207-214). Furthermore, in the purification process, since the desired PHA is extracted from microbial cells containing various compounds, there is a limit in improving the purity in industrial production. Thus, the production of PHA by microbial fermentation has various problems.
- PHA polyhydroxyalkanoate synthase
- PHA other than PHB can be synthesized by the same in vitro polymerization method, and the PHA variation that could not be achieved by the microbial fermentation method is no longer restricted, and the variation of PHA is greatly expanded.
- Biomacromolecules, 2000, 1, 433-439, Appl. Microbiol. BiotechnoL, 2001, 56, 131-136, Macromolecules, 2001, 34, 6889-6894 In this method, it is possible to synthesize not only a homopolymer but also a copolymer.
- acyl CoA in an in vitro polymerization method, acyl CoA must be used as a reaction starting material, but as described above, its synthesis has various problems. For this reason, the amount of acyl CoA used can be kept to an extremely small amount, and a method for producing a polymer compound using other compounds that can be easily synthesized industrially as starting materials The development of is desired.
- acyl CoA is used as an enzyme substrate, and the enzyme is reacted to polymerize PHA, and the released CoA is released into the reaction system ( The following formula).
- R is R.
- One SH is an organic group representing CoA
- R 1 is an arbitrary alkylene
- n is an integer corresponding to the degree of polymerization.
- acyl CoA must be used as a reaction substrate.Since acyl CoA is very expensive, phA is industrially used while using it as a reaction substrate. It must be said that it is extremely difficult to reduce the production cost of PH if it is produced in a low volume. Also, recycling CoA to acyl CoA requires a variety of enzymes that are difficult to obtain, and requires expensive compounds such as ATP. Furthermore, in the production method using PHA organisms, especially microorganisms, the variation of PHA is limited, and it is very likely that the copolymer will be polymerized by metabolism in the organism, so that only the desired PHA is produced. It can be difficult to do. For these reasons, there has been a demand for the development of a production method that reduces the production cost of PH by using, as a starting material, a compound that has many variations of PHA and can be easily synthesized in its production. Disclosure of the invention
- the present invention provides an industrial acyl transferase reaction method using a CoA enzyme in an acyl CoA regeneration system, and in particular, an acylole transferase reaction method useful for production of biologically active substances such as biological substances.
- the task is to
- CoA coenzyme
- an object of the present invention is to provide a method capable of efficiently producing a biodegradable polymer compound useful in an enzymatic reaction with a catalytic amount of a capture enzyme (CoA).
- the present inventors have made intensive studies on the efficiency, speed, cost, selectivity, and the possibility of coupling with an enzymatic reaction for a regenerating system of acyl CoA, and as a result, a chemical synthesis method that has been used only for preparation so far.
- the inventors have found that one of the thioester exchange reactions can be coupled with an enzyme reaction system, and completed the present invention.
- This thioester exchange reaction proceeds in a neutral to weakly basic system, and the substrate specificity of the acyl group is extremely wide. Therefore, the CO enzyme that exhibits reactivity in the region where thioester exchange reaction can occur Coupling is possible with any of the above. Furthermore, the present inventors applied this coupling method to serine. C-palmitoyltransferase, which is a key enzyme in the sphingolipid biosynthesis pathway, to convert fatty acid via CoA from thiophenol fatty acid and serine. We succeeded in establishing a method for producing sphingoid bases, which are important bioactive substances, by decarboxylation of the chain.
- the present inventors have conducted intensive studies to find new synthetic routes for various compounds related to PHA from organic compounds in order to develop a highly efficient method for producing PHA.
- the reaction starting material can be replaced with a thiophenyl ester that can be easily synthesized.
- the regeneration reaction of acyl CoA which is indispensable for the polymerization reaction, can also be performed.
- the present inventors have found that the present invention can be carried out in the same reaction solution system, and that it is possible to drastically reduce the amount of acyl C A A while suppressing the concentration of C A A, thereby completing the present invention.
- the present invention relates to the following acyl transferase reaction method.
- acyltransferase reaction that transfers the acyl group of acylcoenzyme A (acyl CoA)
- acyl CoA acyl CoA
- a chemical thioester exchange reaction between the thiol compound and an acyl group donor, which is an acyl acylate is carried out from enzyme A. It is possible to react by producing and / or regenerating acyl-enzyme A in the reaction system. And a method of reacting an acyltransferase.
- the reaction system simultaneously contains an acyl group donor, an acyl group acceptor, a coenzyme A, and an amyltransferase, and transfers the amyl group of the amyl group donor to koenzyme A by a chemical thiol exchange reaction.
- the reaction system simultaneously contains an acyl group donor, an acyl group acceptor, a coenzyme II, and an acyltransferase, and the acyl group of the acyl group donor is transferred to the enzyme II by a chemical ester exchange reaction.
- Te A wherein in the reaction for transferring the acyl group of the acyl group A to an acyl group receptor, the acyl transferase is a high-molecular-weight polymerizing enzyme, and Group transferase reaction method.
- Ralstonia eutropha is Ralstonia eutropha ATCC 17699.
- FIG. 1 is a scheme showing a power coupling reaction with an acyl CoA regeneration system by thioester exchange according to the present invention.
- an acyl group donor, an acyl group acceptor, CoA, and an acyltransferase (CoA enzyme) are present in one system, and are consumed as the reaction proceeds.
- the transfer of the acyl group can be carried out by a coupling reaction in which the acyl CoA is produced and regenerated by a chemical thioester exchange reaction between the acyl group donor and coenzyme A in the same system as the enzymatic reaction.
- acyl C o A consumed by the progress of the reaction Is produced and regenerated by a chemical thioesterification reaction. This results in expensive files.
- o Efficient acyl transfer reaction can be realized only by allowing a small amount of A to be present in the reaction system.
- the product obtained by acyl CoA or transacylation reaction is further defined as an acyl group acceptor.
- an efficient polymer formation reaction can be realized by repeating the acyl group transfer reaction.
- the second embodiment (polymer formation reaction) is a part of the first embodiment (high-efficiency acyl group transfer reaction).
- first embodiment high-efficiency acyl group transfer reaction
- second embodiment polymer formation reaction
- the Co A enzyme used in this embodiment is not particularly limited, except that acyl Co A is used as a capture factor (capsule).
- these enzymes include acetylglutamate synthase (EC 2.3.1.1), acetoacetyl CoA thiolase (EC 2.3.1.19), and serine C-palmitoyltransferase (EC 2.3). 1.50), etc., and transferases belonging to the “EC 2.3.1.x” series.
- These enzymes have been shown to exist in many organisms, and have been isolated and purified from various organisms (Enzyme Nomenclature, 178-199, Academic Press, INC. (1992)). Among them, enzymes exhibiting an optimum pH in a neutral to weakly basic range are more preferable.
- CoA enzymes may be purified enzymes, but catalytic cells having CoA enzyme activity or processed products thereof can also be used. However, in this case, it is desirable to avoid the effects of enzymes other than those that use acyl CoA as a capture factor, by using a defective mutant, inhibiting the activity, or inactivating it.
- the acyl donor used in the highly efficient transacylation according to the invention is C
- C an acyl ester of a thiol compound
- acyl thioester which is capable of non-catalytic thioester exchange reaction with A
- aromatic thiols include: thiophenol, methinolate phenol, chlorothiophenol, 2-mercaptothiazole, 2-mercaptoimidazole, 2-mercaptotriazole, 2-mercaptobenzothiazole, 2-mercaptobenzoimidazole And 2-mercaptopyridine.
- Particularly preferred examples include acyl esters of thiophenol (also referred to simply as "thiophenyl ester" in the present application, including cases where the phenyl group has a substituent).
- acyl group corresponding to the thiol of the acyl ester there can be basically used without any restriction.
- the alkyl chain of the aliphatic acyl group may be substituted, and a part or all of the alkyl chain may be cyclic.
- the aromatic ring of the aromatic acyl group may be a carbocyclic ring, a heterocyclic ring or a condensed ring, and may be optionally substituted.
- the substituent include a hydroxyl group, an alkyl group, an aryl group, an aralkyl group, an amino group, and halogens such as chlorine and bromine.
- acyl group acceptor used in the high-efficiency acyl group transfer reaction according to the present invention as long as it can be used as a substrate for the CoA enzyme.
- substrate specificity of enzyme By changing the enzyme according to the reaction conditions, or using a mutant whose substrate specificity has been altered by protein engineering, a substance that is not an ordinary suitable substrate of the enzyme can also be used as the acyl group receptor.
- Preferred isyl group receptors are amino acids and amino acid derivatives, with natural amino acids and unnatural amino acids being particularly preferred.
- the amino acid is serine and the enzyme is serine C-palmitoyltransferase
- an efficient synthesis reaction of 3-ketodihydro sphingosine is obtained.
- the acyl group receptor is sphingosine, which is an amino acid derivative
- the enzyme is sphingosine N-acyltrans fluorescase
- the reaction is an efficient ceramide synthesis reaction.
- the product in the acyl group transfer reaction does not necessarily have the transferred acyl group as it is, and may undergo decarboxylation or rearrangement under the reaction conditions, and is generally determined by the enzyme and substrate used.
- CoA used in the high-efficiency transacylation reaction according to the present invention may be produced by any method such as a chemical synthesis method, a semi-synthesis method, and a biological fermentation method, and can function as CoA. I just want it.
- the reaction system used is a transesterification reaction of the acyl group donor and CoA, and the conversion of acyl CoA to the acyl group acceptor by the CoA enzyme used.
- a transesterification reaction of the acyl group donor and CoA and the conversion of acyl CoA to the acyl group acceptor by the CoA enzyme used.
- the reaction of the present invention may be performed at a temperature at which the stability of the CoA enzyme is ensured and the reaction proceeds.
- the temperature is usually from 10 ° C to 45 ° C, preferably from 20 ° C to 40 ° C.
- the reaction of the present invention is not particularly limited as long as the stability of the CoA enzyme is ensured and the reaction proceeds with respect to the concentration.
- the reaction system may be an open type or a closed type. If odor or the like becomes a problem, the reaction may be performed in a closed system.
- the present invention is also useful as a polymer generation reaction. Specifically, a polymer for synthesizing a polymer compound from a thioester in a solution in which a thioester exchange reaction and a polymer synthase reaction coexist.
- the present invention relates to a method for producing a compound.
- the polymer compound synthesized in the present invention is not limited as long as it is a high molecular compound synthesized from a thioester in a solution in which a thioester exchange reaction and a high-molecular-weight polymerizing enzyme reaction coexist.
- Examples include polyhydroxyalkanoate (PHA), which is reported to be produced mainly by fermentative production of microorganisms. More than 90 species are known (FEMS Microbiol. Lett., 1995, 128, 219).
- those having an alkyl chain of C2 or more in the side chain those having a long-chain alkyl group of C6 or more, or C10 or more, and an alkyl group branched to the side chain
- those having a phenyl ring in the side chain those having a modifying group in the phenyl ring, those having a phenoxy ring in the side chain, and those having a modifying group in the phenyl ring Having a double bond or a triple bond in the side chain, showing good polymerizability in it, having a halogen element in the side chain, having a cyclo ring in the side chain, and having an epoxy ring in the side chain And the like.
- PHAs can be homopolymers or copolymers composed of two or more units.
- Alkyl group Int. J. Biol. Macromol., 1990, 12, 92-101
- phenyl ring Macromol. Chem., 1990, 191, 1957-1965, Macromolecules, 1991, 24, 5256-5260, Macromolecules, 1996, 29, 1762-1766, etc.
- phenoxy ring Macromolecules, 1996, 29, 3432-3435, Macromol. Chem. Phys., 1994, 195, 1665-1672, etc.
- For double bonds see Appl. Environ. Microbiol., 1988, 54, 2924-2932, Int. J. Biol.
- polymer compound examples include poly (3-hydroxyalkanoate) and poly (4-hydroxyalkanoate), which are well known to be produced mainly by fermentation of living organisms, especially microorganisms. I can do it. Furthermore, specifically, poly (3-hydroxybutyrate) can be specifically mentioned. These are merely examples, and all polymer compounds containing a polymer unit capable of forming a polymer by the method of the present invention are included. Further, a combination of a plurality of types of polymerization units may be included. The degree of polymerization is not particularly limited as long as the enzymatic reaction proceeds.
- high-molecular-weight polymerization enzyme reaction that can be used in the present invention, and examples thereof include a reaction using hydroxyalkanoate-coenzyme A as acylchoenzyme A. Generated by the PHA.
- the high-molecular-weight polymerizing enzyme used in the present invention may be a high-molecular-weight polymerizing enzyme that synthesizes a high-molecular compound using the substance produced by the thioester exchange reaction of the present invention as a substrate.
- a high-molecular-weight polymerizing enzyme that synthesizes a high-molecular compound using the substance produced by the thioester exchange reaction of the present invention as a substrate.
- PHA polyhydroxyalkanoate synthase
- a wide variety of methods can be used to obtain high-molecular-weight polymerizing enzymes, such as extraction and purification from biological cells and extraction and purification from biological cultures.
- PHAS can be extracted and purified from microbial cells. I can do it.
- the amount of the enzyme that can be obtained by ordinary extraction and purification methods is extremely small, and in recent years, the PHAS gene has been isolated using genetic recombination technology (J. Biol. Chem ,, 1989, 264). , 15298-15303, J. Bacteriol., 1988, 170, 4431-4436, J. Bacteriol., 1988, 170, 5837-5847). Biochemistry, 1994, 33, 9311-9320, Protein Expression Purif., 1996, 7, 203-211).
- an enzyme modified by a technique such as an immobilized enzyme can also be used.
- the biological species derived from the high molecular weight polymerizing enzyme used in the present invention examples thereof include the genus Ralstonia, Pseudomonas, and Chromatium, which are well known for the production of PHA. ) It can control many microorganisms including the genus Ectothiorhodospira. It is also possible to obtain a high-molecular-weight synthase from a genetically-modified product having the high-molecular-weight synthase gene derived from these organisms as a donor.
- the PHAS gene of Ralstonia eutropha ATCC17699 is isolated, a recombinant Escherichia coli is produced and cultured, and the desired PHAS is extracted and purified from the culture product. It can be used as a catalyst for polymer polymerization reaction.
- the acyl group donor used in the polymer generation reaction according to the present invention is the same as the above-mentioned highly efficient acyl group transfer reaction except that the acyl group can be a structural unit of the polymer.
- This thioester can easily undergo a thioester exchange reaction to convert it into acyl CoA, which is a thioester of CoA, by coexisting with a CoA salt under an alkaline condition (Int. Symp. Bacterial. Polyhydroxyalkanoates, 1996, 28-35).
- CoA thioester is used as an enzyme substrate, and the enzyme reacts to polymerize PHA, and liberated CoA is released into the reaction system.
- the C0A thioester includes both those charged at the beginning of the reaction and those generated by the progress of the reaction. In any case, the products are a polymer and C0A (the following formula).
- R is R.—SH is an organic group representing CoA
- R 1 is an arbitrary alkylene
- n is an integer corresponding to the degree of polymerization.
- the present invention is implemented by combining the above two reactions, that is, the two reactions of the thioester exchange reaction and the polymer polymerization reaction, and coexisting them in one reaction system.
- a polymer compound is produced.
- CoA released into the reaction system after the polymerization reaction and not reused was reacted with the thioester introduced into the reaction system to synthesize the thioester of CoA again. At least, this is used again as a substrate for the polymerization reaction (the following formula).
- the present invention is a method for producing PHA with high efficiency.
- the reaction conditions of the present invention are not particularly limited and are the same as in the high-efficiency transamination reaction.
- the conditions for promoting the enzymatic reaction include a temperature of 0 ° C to 60 ° C, preferably The temperature is preferably from 10 to 50 ° C, more preferably from 20 to 40 ° C.
- the reaction can be conveniently carried out at room temperature.
- 11 be carried out between 3 and 12, preferably between 5 and 10, and more preferably between 7 and 9.
- the condition in which the thioester exchange reaction and the polymer polymerization reaction coexist means that the thioester exchange reaction and the polymer polymerization reaction are present in the same aqueous solution, organic solvent, or a mixed solution thereof, or in the same reaction vessel. Is a situation where one kind of solution or a plurality of solutions exist in a mixed state or a separated state. In the case of a layered structure, the separation state may be oil droplets or visually suspended. Etc. are included. In any case, it suffices that the state necessary for the thioester exchange reaction and the polymer polymerization reaction be integrated and ensured. Then, as a starting material, a thioester that can be produced industrially efficiently is used, and this is used in the reaction system.
- the thioester of CoA is used as a substrate for the polymerization reaction to produce a polymer compound.
- Example 1 Synthesis of acylthiophenol (thiophenyl palmitate) 6 mL of anhydrous dichloromethane was added to a well-dried and nitrogen-substituted flask, and the mixture was stirred well while cooling on ice. Thereto, 2 mL of 2 M trimethylaluminum was slowly added. In addition, thiophenol was added slowly. After stirring at room temperature for 1 hour and 30 minutes, ethyl ethyl palmitate dissolved in 6 mL of anhydrous dichloromethane was slowly added and reacted. The reaction was monitored by TLC.
- SPT Serine C-palmitoyltransferase
- primers (SEQ ID NO: 1 and SEQ ID NO: 2) encoding the N-terminal sequence and C-terminal sequence were prepared from the entire base sequence of the above SPT, and the chromosomal DNA of Snhingomonas paucimobilis was mirrored under the following conditions.
- a DNA fragment corresponding to the SPT coding region was prepared by PCR.
- the N-terminal primer was provided with an NcoI site for connection of the vector
- the C-terminal primer was provided with a HindIII site.
- the prepared PCR fragment was subjected to agarose gel electrophoresis, extracted from the gel, and recovered by a column. This fragment was treated with the restriction enzyme NcoI-HindIII, ligated with the NcoI-Hindlll fragment of the plasmid pET21d, and transformed into the host E. coli BL21 (DE3) strain. The resulting transformant was cultured in 5 mL of an LB medium containing 50 ppm of ampicillin at 35 ° C. for 16 hours, and the cells were collected by centrifugation and washed with physiological saline.
- Example 3 Power coupling between transesterification reaction and CoA enzyme reaction (water homogenous system) 2 mg of CoA sodium salt and 1 mg of L-serine in 100 mM HEPES-NaOH buffer (including ⁇ PL ⁇ , (pH 8.0) dissolved in 5 mL, and stirred well with a magnetic stirrer. A solution obtained by dissolving 3.5 mg of thiophenol palmitate in 0.1 mL of acetonitrile was mixed therewith. The stirring speed was reduced to such an extent that it was mixed gently, and 0.5 mL of the SPT crude enzyme solution was added, and the mixture was reacted at 37 ° C. for 24 hours.
- reaction solution 75 described below was taken, added with 425 L of a 70.6 mM triethylamine Z ethanol solution, and stirred. The precipitate was removed by centrifugation for 5 minutes, the supernatant was taken at 100 / zL into an HP LC sample vial (300 ⁇ L micro insert), AQC reagent (Waters) solution was added, and the mixture was immediately stirred. After reacting at room temperature for more than 40 minutes, analysis was performed under the following HP LC conditions.
- LC-VP series Shiadzu Corporation
- LC-10ADVP Force ram oven CTO-10ACVP
- Autosampler SIL-10AF System controller SCL-10AVP
- Fluorescence detector 821-FP JASCO
- Ex.244nm Em.398nm
- GainxlOO Column SHODEXF-511A, 35 ° C
- Example 4 Power coupling between transesterification reaction and CoA enzymatic reaction (oil-water two-layer system) 2 mg of CoA sodium salt and 1 mg of L-serine in 100 mM HEPES-NaOH buffer solution ( ⁇ ⁇ PLP) (PH 8.0) was dissolved in 5 mL, and the mixture was stirred well with a magnetic stirrer. A solution in which 3.5 mg of thiophenyl palmitate was dissolved in 5 mL of hexane was mixed therewith.
- the extract was dried over magnesium sulfate, evaporated under reduced pressure, and dried under vacuum to obtain 3- (t-butyldimethylsilyl) butyrate. On ice, dissolve 870 mg of 3- (t-butyldimethylsilyl) butyrate and 452 mg of thiophenol in 6 ml of dichloromethane and add 2 ml of dichloromethane.
- Reference Example 4 Preparation and purification of enzyme Ralstonia eutropha ATCC 17699 genomic DNA cuts out restriction enzymes EcoRI and SmaI fragment (approximately 5 kbp), clones them into pUC18 and adds PHA synthase gene (PHAS). Mid pTI305 was obtained. Next, a BamH I ⁇ Not I fragment (140 bp) of the DNA amplified by PCR with the following two primers using pT I 305 as a template and pT I 305 as a template And three types of BamHI and SmaI fragments of vector pQE30 (manufactured by Qiagen) were mixed and ligated to prepare plasmid pQEREC.
- Escherichia coli BL21 This was introduced into Escherichia coli BL21 (pREP4) to prepare Escherichia coli BL21 (pQEREC) for enzyme preparation.
- the Escherichia coli was cultured in 1000 ml of LB medium at 30 ° C. for 16 hours to accumulate enzymes in the cells, disrupted the cells by sonication, and then recovered soluble proteins in the cells.
- This protein was passed through a Ni-NTA agarose gel column, and (His) -PhaC (six histidines were added to the N-terminus) was specifically adsorbed to the column. After washing, (His) -Pha C was eluted with imidazole, and 1 Omg was obtained as a purified enzyme after dialysis.
- the molecular weight of the enzyme was 65 kDa on SDS-PAGE.
- Sense Pfima aaggatccatggcgaccggcaaaggcgcgg (robot system (J ⁇ " ⁇ 3), antisense primer: tgcagcggaccggtggcctcggcctgccc (configuration lj number 4), cycle: (94 ° C 45 seconds, 58 ° C 30 seconds, 72 ° C 60 seconds) X 30 cycles
- Example 5 Polymerization of poly ((R) -3-hydroxybutyrate)
- 0.015 mg of the enzyme was added to 5 ml of a 10 OmM potassium phosphate solution, and the mixture was stirred well at room temperature. Keep the solution temperature at 30 ° C by slightly lowering the stirring speed, and add 5 ml of lmMC 0A sodium solution and 0.5 ml of 2 OmM 3 A solution of hydroxybutylate thiophenylester (dissolved in a 1: 1 solution of potassium phosphatase solution and acetonitrile) was added little by little, and the mixture was further reacted at 30 ° C. for 24 hours. Next, this solution was washed three times with 2 Oml of hexane, and the product in the solution was extracted and recovered with a 1 Om1 pore-form.
- 0.015 mg of the enzyme was added to 5 ml of a 100 mM potassium phosphate solution, and the mixture was stirred well at room temperature.
- the solution temperature was kept at 30 ° C by lowering the stirring speed slightly, and 5 ml of the lmM3-hydroxybutyrate CoA solution and 0.5 ml of the 20 mM 3-hydroxybutyrate thiophenylester solution (100 ml mM potassium phosphate solution and acetonitrile in 1: 1 solution) were added little by little, and the mixture was further reacted at 30 ° C. for 24 hours.
- 0.015 mg of the enzyme was added to 5 ml of a 10 OmM potassium phosphate solution, and the mixture was stirred well at room temperature. Reduce the agitation speed to a low level, and add 5 ml of 1 mM (R, S) 13-hydroxyvalerate CoA and 0.5 ml of 2 OmM3 —hydroxyvalerate. (Dissolved in a 1: 1 solution of a 10 OmM potassium phosphate solution and acetonitrile) was added little by little, and the mixture was further reacted at room temperature for 24 hours. Next, this solution was washed three times with 20 ml of hexane, and the product in the solution was extracted and recovered with a 1 Om 1 pore-form.
- Example 8 Polymerization of poly ((R) -3-hydroxybutyrate) from (R) -3-hydroxybutyrate thiophenol ester
- the reaction is carried out continuously without adding an extremely expensive acylcoenzyme A (acyl CoA), thereby dramatically improving the productivity. can do. Therefore, various compounds can be produced by a novel coupling method that enables the use of an acyltransferase in an industrial production method.
- a thioester exchange reaction is combined with an enzymatic reaction to accumulate and produce sphingoid bases without a cytotoxicity problem, which has been difficult with a conventional enzymatic method.
- the regeneration reaction of capture enzyme CoA which is indispensable for the reaction, can be performed in the same reaction solution, dramatically reducing coenzyme consumption and economically reducing sphingoid bases. Can be manufactured.
- various sphingoid bases can be produced inexpensively and purely, and the use thereof is dramatically expanded.
- the reaction starting material is replaced with a thiophenyl ester that can be easily synthesized, and is essential for the polymerization reaction.
- the regeneration reaction of the capture enzyme CoA can also be performed in the same reaction solution system, dramatically reducing the consumption of the capture enzyme, and making various PHs inexpensive, efficient and industrial. It can be manufactured and its applications are dramatically expanded.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04703935.9A EP1591531B1 (en) | 2003-01-22 | 2004-01-21 | Process for acyl-transfer enzyme reactions with acyl- coenzyme a |
US10/542,733 US7476521B2 (en) | 2003-01-22 | 2004-01-21 | Method for acyltransferase reaction using acyl coenzyme A |
JP2005508108A JP4353484B2 (ja) | 2003-01-22 | 2004-01-21 | アシルコエンザイムaを用いるアシル基転移酵素反応方法 |
US12/277,622 US7943351B2 (en) | 2003-01-22 | 2008-11-25 | Method for acyltransferase reaction using acyl coenzyme A |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-13762 | 2003-01-22 | ||
JP2003013762 | 2003-01-22 | ||
JP2003094881 | 2003-03-31 | ||
JP2003-94881 | 2003-03-31 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10542733 A-371-Of-International | 2004-01-21 | ||
US12/277,622 Division US7943351B2 (en) | 2003-01-22 | 2008-11-25 | Method for acyltransferase reaction using acyl coenzyme A |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004065609A1 true WO2004065609A1 (ja) | 2004-08-05 |
Family
ID=32775174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/000500 WO2004065609A1 (ja) | 2003-01-22 | 2004-01-21 | アシルコエンザイムaを用いるアシル基転移酵素反応方法 |
Country Status (4)
Country | Link |
---|---|
US (2) | US7476521B2 (ja) |
EP (1) | EP1591531B1 (ja) |
JP (1) | JP4353484B2 (ja) |
WO (1) | WO2004065609A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2060594A2 (en) | 2007-11-14 | 2009-05-20 | National University Corporation Hokkaido University | Method for producing polymer |
JP2009138174A (ja) * | 2007-11-14 | 2009-06-25 | Agri Bioindustry:Kk | 高分子化合物の製造方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008537878A (ja) * | 2005-03-18 | 2008-10-02 | マイクロビア, インコーポレイテッド | 含油性酵母および真菌におけるカロテノイドの産生 |
FR2963362B1 (fr) | 2010-07-30 | 2012-08-17 | Pcas Biosolution | Procede d'acylation enzymatique avec un donneur acyl-phosphonate |
CN109896955A (zh) | 2019-03-26 | 2019-06-18 | 沈阳金久奇科技有限公司 | 一种β-羟基羧酸酯的制备方法 |
DE202019105611U1 (de) | 2019-10-11 | 2019-10-30 | Shenyang Gold Jyouki Technology Co., Ltd. | beta-Hydroxycarbonsäureester, hergestellt durch eine Carbonylierungsveresterungsreaktion in einer Kohlenmonoxidatmosphäre mittels eines Co-Katalysators |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57150393A (en) | 1980-11-18 | 1982-09-17 | Ici Ltd | Beta-hydroxy butyrate polymer and production thereof |
EP0114086A2 (en) | 1983-01-18 | 1984-07-25 | Imperial Chemical Industries Plc | Production of beta-hydroxybutyrate polymers |
EP0274151A2 (en) | 1986-12-02 | 1988-07-13 | Rijksuniversiteit te Groningen | A process for producing polyesters by fermentation; a process for producing optically active carboxylic acids and esters; articles of manufacture comprising polyester |
JPS63269989A (ja) | 1987-04-28 | 1988-11-08 | Yoshiharu Doi | 共重合体の製造法 |
JPS6448821A (en) | 1987-08-18 | 1989-02-23 | Mitsubishi Chem Ind | Polyester copolymer and its production |
JPH01156320A (ja) | 1987-12-15 | 1989-06-19 | Mitsubishi Kasei Corp | ポリエステル共重合体およびその製造方法 |
JPH01222788A (ja) | 1988-03-02 | 1989-09-06 | Mitsubishi Kasei Corp | ポリエステル共重合体の製造方法 |
JPH0593049A (ja) | 1991-09-17 | 1993-04-16 | Kanegafuchi Chem Ind Co Ltd | 共重合体およびその製造方法 |
JPH07265065A (ja) | 1994-03-29 | 1995-10-17 | Kanegafuchi Chem Ind Co Ltd | 共重合体の合成遺伝子による形質転換体および共重合体の製造方法 |
JPH10108682A (ja) | 1996-08-14 | 1998-04-28 | Rikagaku Kenkyusho | ポリエステル重合酵素遺伝子及びポリエステルの製造方法 |
WO1999014313A2 (en) | 1997-09-19 | 1999-03-25 | Metabolix, Inc. | Biological systems for manufacture of polyhydroxylalkanoate polymers containing 4-hydroxyacids |
WO2002008428A2 (en) * | 2000-07-21 | 2002-01-31 | Metabolix, Inc. | Production of polyhydroxyalkanoates from polyols |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6448821U (ja) | 1987-09-18 | 1989-03-27 | ||
AU2001285041A1 (en) * | 2000-08-18 | 2002-03-04 | Metabolix, Inc. | Sulfur containing polyhydroxyalkanoate compositions and method of production |
-
2004
- 2004-01-21 JP JP2005508108A patent/JP4353484B2/ja not_active Expired - Fee Related
- 2004-01-21 WO PCT/JP2004/000500 patent/WO2004065609A1/ja active Application Filing
- 2004-01-21 US US10/542,733 patent/US7476521B2/en not_active Expired - Fee Related
- 2004-01-21 EP EP04703935.9A patent/EP1591531B1/en not_active Expired - Lifetime
-
2008
- 2008-11-25 US US12/277,622 patent/US7943351B2/en not_active Expired - Fee Related
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57150393A (en) | 1980-11-18 | 1982-09-17 | Ici Ltd | Beta-hydroxy butyrate polymer and production thereof |
US4393167A (en) | 1980-11-18 | 1983-07-12 | Imperial Chemical Industries Plc | Polymer blends containing polymer of β-hydroxybutyric acid and chlorine or nitrile group containing polymer |
EP0114086A2 (en) | 1983-01-18 | 1984-07-25 | Imperial Chemical Industries Plc | Production of beta-hydroxybutyrate polymers |
JPS59220192A (ja) | 1983-01-18 | 1984-12-11 | インペリアル・ケミカル・インダストリ−ズ・ピ−エルシ− | ベ−タ・ヒドロキシブチレ−ト重合体の製造方法 |
EP0274151A2 (en) | 1986-12-02 | 1988-07-13 | Rijksuniversiteit te Groningen | A process for producing polyesters by fermentation; a process for producing optically active carboxylic acids and esters; articles of manufacture comprising polyester |
JPS63226291A (ja) | 1986-12-02 | 1988-09-20 | リジュクスユニバシテイト テ グロニンゲン | 酵素によるポリエステルの製造方法,光学活性カルボン酸およびエステルの製造方法,およびポリエステルを含む製品 |
JPS63269989A (ja) | 1987-04-28 | 1988-11-08 | Yoshiharu Doi | 共重合体の製造法 |
JPS6448821A (en) | 1987-08-18 | 1989-02-23 | Mitsubishi Chem Ind | Polyester copolymer and its production |
JPH01156320A (ja) | 1987-12-15 | 1989-06-19 | Mitsubishi Kasei Corp | ポリエステル共重合体およびその製造方法 |
JPH01222788A (ja) | 1988-03-02 | 1989-09-06 | Mitsubishi Kasei Corp | ポリエステル共重合体の製造方法 |
JPH0593049A (ja) | 1991-09-17 | 1993-04-16 | Kanegafuchi Chem Ind Co Ltd | 共重合体およびその製造方法 |
JPH07265065A (ja) | 1994-03-29 | 1995-10-17 | Kanegafuchi Chem Ind Co Ltd | 共重合体の合成遺伝子による形質転換体および共重合体の製造方法 |
JPH10108682A (ja) | 1996-08-14 | 1998-04-28 | Rikagaku Kenkyusho | ポリエステル重合酵素遺伝子及びポリエステルの製造方法 |
WO1999014313A2 (en) | 1997-09-19 | 1999-03-25 | Metabolix, Inc. | Biological systems for manufacture of polyhydroxylalkanoate polymers containing 4-hydroxyacids |
JP2001516574A (ja) | 1997-09-19 | 2001-10-02 | メタボリックス,インコーポレイテッド | 4−ヒドロキシ酸を含むポリヒドロキシアルカノエートポリマー製造のための生物学的システム |
WO2002008428A2 (en) * | 2000-07-21 | 2002-01-31 | Metabolix, Inc. | Production of polyhydroxyalkanoates from polyols |
Non-Patent Citations (56)
Title |
---|
"Enzyme Nomenclature", 1992, ACADEMIC PRESS, INC., pages: 178 - 199 |
ANALYTICAL BIOCHEMISTRY, vol. 298, 2001, pages 283 - 292 |
ANTONIO R.V. ET AL: "Analysis of in vivo substrate specificity of the PHA synthase from Ralstonia eutropha: formation of novel copolyesters in recombinant Escherichia coli", FEMS MICROBIOLOGY LETTERS, vol. 182, no. 1, 2000, pages 111 - 117, XP002979705 * |
APPL. ENVIRON. MICROBIOL, vol. 54, 1988, pages 2924 - 2932 |
APPL. MICROBIOL. BIOTECHNOL., vol. 40, 1994, pages 699 - 709 |
APPL. MICROBIOL. BIOTECHNOL., vol. 49, 1998, pages 258 - 266 |
APPL. MICROBIOL. BIOTECHNOL., vol. 56, 2001, pages 131 - 136 |
BIBEL ET AL., J. INVEST. DERMATOL., vol. 93, 1992, pages 269 - 273 |
BIOMACROMOLECULES, vol. 1, 2000, pages 433 - 439 |
BIOORGANIC CHEM., vol. 18, 1990, pages 131 - 135 |
CURATOLO, PHARM. RES., vol. 4, 1987, pages 271 - 277 |
EUR. J. BIOCHEM., vol. 226, 1994, pages 71 - 80 |
FEMS MICROBIOL. LETT., vol. 128, 1995, pages 219 |
FEMS MICROBIOL. LETT., vol. 128, 1995, pages 219 - 228 |
FEMS MICROBIOL. REV., vol. 103, 1992, pages 207 - 214 |
FEMS MICROBIOLOGY LETTERS,, vol. 168, 1998, pages 319 - 324 |
H. IKUSHIRO, THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, 2001, pages 18249 - 18256 |
INT. J. BIOL. MACROMOL., vol. 12, 1990, pages 85 - 91 |
INT. J. BIOL. MACROMOL., vol. 12, 1990, pages 92 - 101 |
INT. SYMP. BACTERIAL POLYHYDROXYALKANOATES, 1996, pages 28 - 35 |
J. AM. CHEM. SOC., vol. 22, 1973, pages 5829 |
J. AM. CHEM. SOC., vol. 75, 1953, pages 2520 |
J. BACTERIOL., vol. 170, 1988, pages 5837 - 5847 |
J. BACTERIOL..,, vol. 170, 1988, pages 4431 - 4436 |
J. BIOCHEMISTRY, vol. 33, 1994, pages 9311 - 9320 |
J. BIOL. CHEM., vol. 260, 1985, pages 13181 |
J. BIOL. CHEM., vol. 264, 1989, pages 15298 - 15303 |
J. CHEM. SOC. POLYM. COMMUN., vol. 31, 1990, pages 404 - 406 |
J. POLYM. SCI. PART A, vol. 33, 1995, pages 1367 - 1374 |
KERSCHER ET AL., EUR. J. DERMATO, vol. 1, 1991, pages 39 - 43 |
M. TANAKA, JOURNAL OF CHROMATOGRAPHY, vol. 284, 1984, pages 433 - 440 |
MACROMOL. CHEM. PHYS., vol. 195, 1994, pages 1665 - 1672 |
MACROMOL. CHEM., vol. 191, 1990, pages 1957 - 1965 |
MACROMOLECULES, vol. 23, 1990, pages 3705 - 3707 |
MACROMOLECULES, vol. 24, 1991, pages 5256 - 5260 |
MACROMOLECULES, vol. 25, 1992, pages 1852 - 1857 |
MACROMOLECULES, vol. 27, 1994, pages 1675 - 1679 |
MACROMOLECULES, vol. 29, 1996, pages 3432 - 3435 |
MACROMOLECULES, vol. 29, 1996, pages 4572 - 4581 |
MACROMOLECULES, vol. 31, 1998, pages 1480 - 1486 |
MACROMOLECULES, vol. 31, 1998, pages 4760 - 4763 |
MACROMOLECULES, vol. 32, 1999, pages 7389 - 7395 |
MACROMOLECULES, vol. 34, 2001, pages 6889 - 6894 |
MACROMOLECULES,, vol. 29, 1996, pages 1762 - 1766 |
MACROMOLECULES,, vol. 33, 2000, pages 229 - 231 |
NAGIEC M.M. ET AL: "The LCB2 gene of Saccharomyces and the related LCB1 gene encode subunits of serine palmitoyltransferase, the initial enzyme in sphingolipid synthesis", PNAS USA, vol. 91, 1994, pages 7899 - 7902, XP002979704 * |
NARIMATSU S. ET AL: "Solubilization and partial characterization of fatty acyl-CoA: sphingosine acyltransferase (ceramide synthetase) from rat liver and brain", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 877, no. 3, 1986, pages 334 - 341, XP002979707 * |
OUYANG T. ET AL: "A New Chemical Method for Synthesizing and Recycling Acyl Coenzyme A Thioesters", JOURNAL OF ORGANIC CHEMISTRY, vol. 56, no. 11, 1991, pages 3752 - 3755, XP002979703 * |
PINTO ET AL., J. BACTERIOL., vol. 174, 1992, pages 2565 - 2574 |
PROC. NATL. ACAD. SCI., vol. 92, 1995, pages 6279 - 6283 |
PROTEIN EXPRESSION PURIF., vol. 7, 1996, pages 203 - 211 |
See also references of EP1591531A4 |
WICKERHAM; STODOLA, J. BACTERIOL., vol. 80, 1960, pages 484 - 491 |
YUAN W. ET AL: "Class I and III Polyhydroxyalkanoate Synthases from Ralstonia eutropha and Allochromatium vinosum: Characterization and Substrate Specificity Studies", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 394, no. 1, 2001, pages 87 - 98, XP002979706 * |
Z. NATURFORSCH., vol. 29C, 1974, pages 469 - 474 |
Z. NATURFORSCH., vol. 30C, 1975, pages 352 - 358 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2060594A2 (en) | 2007-11-14 | 2009-05-20 | National University Corporation Hokkaido University | Method for producing polymer |
JP2009138174A (ja) * | 2007-11-14 | 2009-06-25 | Agri Bioindustry:Kk | 高分子化合物の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
EP1591531A4 (en) | 2010-01-27 |
US7476521B2 (en) | 2009-01-13 |
US7943351B2 (en) | 2011-05-17 |
JP4353484B2 (ja) | 2009-10-28 |
JPWO2004065609A1 (ja) | 2006-05-18 |
US20090111153A1 (en) | 2009-04-30 |
US20060148048A1 (en) | 2006-07-06 |
EP1591531A1 (en) | 2005-11-02 |
EP1591531B1 (en) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ruth et al. | Efficient production of (R)-3-hydroxycarboxylic acids by biotechnological conversion of polyhydroxyalkanoates and their purification | |
Ren et al. | Bacterial poly (hydroxyalkanoates) as a source of chiral hydroxyalkanoic acids | |
Wescott et al. | The solvent dependence of enzyme specificity | |
CN102027125B (zh) | 己二酸酯或硫代酯合成 | |
Parthasarathy et al. | Substrate specificity of 2-hydroxyglutaryl-CoA dehydratase from Clostridium symbiosum: toward a bio-based production of adipic acid | |
CA2622537C (en) | Biocatalytic manufacturing of (meth)acrylic esters | |
EP2236613B1 (en) | Biochemical synthesis of 1,4-butanediamine | |
JP2006204255A (ja) | アセチル−CoAアシルトランスフェラーゼ遺伝子破壊ポリヒドロキシアルカノエート生産菌、またこれを利用したポリヒドロキシアルカノエート生産方法 | |
US7943351B2 (en) | Method for acyltransferase reaction using acyl coenzyme A | |
WO2017209102A1 (ja) | 3-ヒドロキシアジピン酸の製造方法 | |
JP6948595B2 (ja) | α−ヒドロムコン酸の製造方法 | |
Takakura et al. | Purification, characterization, and gene cloning of a novel aminoacylase from Burkholderia sp. strain LP5_18B that efficiently catalyzes the synthesis of N-lauroyl-l-amino acids | |
Habulin et al. | Enzymatic synthesis of citronellol laurate in organic media and in supercritical carbon dioxide | |
AU2005224378B2 (en) | Biocatalytic manufacturing of (meth)acrylylcholine or 2-(N,N-dimethylamino)ethyl (meth)acrylate | |
Hacking et al. | Lipase catalysed acylation of hydroxylamine and hydrazine derivatives | |
Valencia et al. | Seven-enzyme in vitro cascade to (3R)-3-hydroxybutyryl-CoA | |
BR112016000541B1 (pt) | Método para produção de metacrilil-coa e conversão de metacrilil-coa em ácido metacrílico ou éster metacrilato | |
Xiong et al. | Genetically Encoded Multienzyme Particles for the Biosynthesis of Putrescine from l-Arginine | |
Pazos Urrea | Concentration and Esterification of Lactic Acid in Complex Coacervates | |
Würges | Enzyme supported crystallization of chiral amino acids | |
JP5595400B2 (ja) | 光学活性3−置換グルタル酸モノアミドの製造法 | |
WO2017082374A1 (ja) | Nε-アシル-L-リジンの製造方法 | |
Lohith | Enzymatic synthesis of selected amino acid esters of sugars | |
Friedrich et al. | H16 Flagellation Ralstonia eutropha | |
JP2007302750A (ja) | ラクトン構造を有する物質を原料とするポリヒドロキシアルカン酸の製造方法およびポリヒドロキシアルカン酸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005508108 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2006148048 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10542733 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004703935 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004703935 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10542733 Country of ref document: US |